Third Rock Ventures is participating in the diabetes-obesity Keystone Symposium co-sponsored by the Endocrine Society.
Public source
Publisher name
Public post
Get ready to join in a very special diabetes-obesity Keystone Symposium (co-sponsored by the Endocrine Society) - our focus is on: basic science breakthroughs; translati…
Company
Third Rock Ventures
- Industry
- Venture Capital and Private Equity Principals
- Location
- Boston, US
- Company size
- 51–200 employees
About Third Rock Ventures
We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAM Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed. A FORMULA FOR INNOVATION We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence. We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices and diagnostics. By creating value for patients, we create value for our investors.
See moreLatest activity
Latest activity from Third Rock Ventures
3 signals
Strategy & Corporate Development
Third Rock Ventures announced that Merida Biosciences team agreed to be acquired by Lilly to bring an entirely new therapeutic modality to precision medicine for autoantibody-driven diseases.
People
Third Rock Ventures welcomed Marit van Buuren as an Entrepreneur in Residence.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
NLC Health Ventures
NLC Health Ventures is supporting the 2nd BioCentury Grand Rounds in Amsterdam from September 23 to 25, 2026.
Presence & Recognition
SOSV
SOSV is hosting the SOSV Deep Tech Summit on November 4, 5, and 6, featuring leaders including Nobel Laureate Jennifer Doudna, David A. Sinclair A.O., Ph.D. (Harvard Medical School), Mike Schroepfer, Milo Werner, Michelle Rozo, Dan Barouch, Thomas Oxley, David Kirtley, and Jenica Patterson.
Presence & Recognition
Forbion
Forbion is hosting the Grand Rounds: Europe 2026 event at BioCentury Inc. in Amsterdam, Netherlands from September 23 to 25.
Presence & Recognition
Pangaea Ventures
Pangaea Ventures Partner Janelle Goulard will be in attendance at the First Annual Summit on Engineering the Elimination of Diseases at Rice University in Houston from September 10 to 11.
Presence & Recognition
Curie Capital